The Nigerian Association of Pharmacists and Pharmaceutical Scientists in the Americas (NAPPSA) Inc has partnered with the US Department of Health and Human Services to help advance the US Government’s objective to expand access to Monoclonal Antibodies (mAbs).
The webinar which is scheduled for Saturday 24 AprIl 2021, 11am, is themed: “Treating COVID-19: Equitable distribution of monoclonal antibodies (mAbs) to reduce hospitalisation and deaths”, will feature speakers like Michael R. Anderson, senior advisor, ASPR,US Dept of HHS and CDR Diana (Lola) Solana-Sodeinde, PharmD, ASPR COVID-19 mAbs, Therapeutics Response Mission, among others.
Following the observed disparities in access to Monoclonal Antibodies (mAbs) for COVID-19 treatment, the US government is investing $150 Million to expand access to COVID-19 treatments in underserved communities.
Whether you are a physician, pharmacist, nurse, other healthcare professionals, a COVID-19 patient, or an individual looking for knowledge that could benefit a friend or family member infected with COVID-19, this webinar is for you.
Details for the ZOOM meeting is as follows:
United States : +16465588656
Meeting ID: 94282184071
Password: 799949
 Inc has partnered with the US Department of){kind=link}